Trending: Bristol Myers Squibb to Buy RayzeBio
27 December 2023 - 2:28AM
Dow Jones News
0958 ET -- Bristol Myers Squibb is one of the most mentioned
companies in the U.S. across all news items in the last 12 hours,
according to Factiva data. The drugmaker has agreed to buy
radiopharmaceutical therapeutics company RayzeBio for $4.1 billion.
Dow Jones & Co. owns Factiva. (colin.kellaher@wsj.com)
(END) Dow Jones Newswires
December 26, 2023 10:13 ET (15:13 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Jul 2023 to Jul 2024